HEADER MYELOPEROXIDASE 15-APR-92 1MYP TITLE X-RAY CRYSTAL STRUCTURE OF CANINE MYELOPEROXIDASE AT 3 ANGSTROMS TITLE 2 RESOLUTION CAVEAT 1MYP CYS A 14 HAS WRONG CHIRALITY AT ATOM CA VAL A 69 HAS WRONG CAVEAT 2 1MYP CHIRALITY AT ATOM CA ILE C 137 HAS WRONG CHIRALITY AT ATOM CAVEAT 3 1MYP CA SER C 156 HAS WRONG CHIRALITY AT ATOM CA LEU C 460 HAS CAVEAT 4 1MYP WRONG CHIRALITY AT ATOM CA ASN C 472 HAS WRONG CHIRALITY AT CAVEAT 5 1MYP ATOM CA ASN C 473 HAS WRONG CHIRALITY AT ATOM CA ASN C 549 CAVEAT 6 1MYP HAS WRONG CHIRALITY AT ATOM CA PRO D 123 HAS WRONG CAVEAT 7 1MYP CHIRALITY AT ATOM CA ALA D 141 HAS WRONG CHIRALITY AT ATOM CAVEAT 8 1MYP CA ASN D 356 HAS WRONG CHIRALITY AT ATOM CA LEU D 458 HAS CAVEAT 9 1MYP WRONG CHIRALITY AT ATOM CA ASN D 549 HAS WRONG CHIRALITY AT CAVEAT 10 1MYP ATOM CA NAG G 1 HAS WRONG CHIRALITY AT ATOM C1 NAG J 1 HAS CAVEAT 11 1MYP WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MYELOPEROXIDASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 1.11.1.7; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: MYELOPEROXIDASE; COMPND 8 CHAIN: C, D; COMPND 9 EC: 1.11.1.7; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CANIS LUPUS FAMILIARIS; SOURCE 3 ORGANISM_COMMON: DOG; SOURCE 4 ORGANISM_TAXID: 9615; SOURCE 5 MOL_ID: 2; SOURCE 6 ORGANISM_SCIENTIFIC: CANIS LUPUS FAMILIARIS; SOURCE 7 ORGANISM_COMMON: DOG; SOURCE 8 ORGANISM_TAXID: 9615 KEYWDS MYELOPEROXIDASE EXPDTA X-RAY DIFFRACTION AUTHOR R.E.FENNA,J.ZENG REVDAT 6 29-JUL-20 1MYP 1 CAVEAT COMPND REMARK HETNAM REVDAT 6 2 1 LINK SITE ATOM REVDAT 5 13-JUL-11 1MYP 1 VERSN REVDAT 4 25-AUG-09 1MYP 1 SOURCE REVDAT 3 24-FEB-09 1MYP 1 VERSN REVDAT 2 01-APR-03 1MYP 1 JRNL REVDAT 1 31-JAN-94 1MYP 0 JRNL AUTH J.ZENG,R.E.FENNA JRNL TITL X-RAY CRYSTAL STRUCTURE OF CANINE MYELOPEROXIDASE AT 3 A JRNL TITL 2 RESOLUTION. JRNL REF J.MOL.BIOL. V. 226 185 1992 JRNL REFN ISSN 0022-2836 JRNL PMID 1320128 JRNL DOI 10.1016/0022-2836(92)90133-5 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.257 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8878 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 256 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : 0.011 ; NULL ; NULL REMARK 3 BOND ANGLES (DEGREES) : 3.800 ; NULL ; NULL REMARK 3 TORSION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES (A) : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS (A) : NULL ; NULL ; NULL REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : NULL REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 THE HUMAN MYELOPEROXIDASE SEQUENCE INCLUDES 4 POTENTIAL REMARK 3 SITES FOR ASPARAGINE-LINKED GLYCOSYLATION IN EACH HALF OF REMARK 3 THE MOLECULE AT POSITIONS: ASN 157, ASN 189, ASN 225, ASN REMARK 3 317. THE AUTHORS DO NOT SEE CLEAR EVIDENCE FOR REMARK 3 GLYCOSYLATION AT ASN 157 IN DOG MYELOPEROXIDASE. AT EACH REMARK 3 OF THE OTHER 3 SITES TWO N-ACETYLGLUCOSAMINES ARE SEEN AND REMARK 3 HAVE BEEN INCLUDED IN THE MODEL. ASN 317 OCCURS AT THE REMARK 3 DIMER INTERFACE AND DENSITY CORRESPONDING TO 3 ADDITIONAL REMARK 3 MANNOSE SUGARS AND A FUCOSE CAN BE SEEN. THESE SUGARS REMARK 3 HAVE NOT BEEN INCLUDED IN THE MODEL BECAUSE THEIR PRECISE REMARK 3 ORIENTATIONS CANNOT BE DETERMINED AT PRESENT. REMARK 4 REMARK 4 1MYP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000175195. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.16 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 101.80000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 66.50000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 66.50000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 50.90000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 66.50000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 66.50000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 152.70000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 66.50000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 66.50000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 50.90000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 66.50000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 66.50000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 152.70000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 101.80000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 30710 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 41110 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -147.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C, B, D, E, F, G, H, I, J REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 EACH HALF-MOLECULE HAS 2 POLYPEPTIDE CHAINS RESULTING FROM REMARK 400 POST-TRANSLATIONAL EXCISION OF RESIDUES 107 TO 112. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A -1 REMARK 465 THR A 0 REMARK 465 ALA A 105 REMARK 465 ARG A 106 REMARK 465 VAL C 113 REMARK 465 ARG C 576 REMARK 465 GLU C 577 REMARK 465 ALA C 578 REMARK 465 VAL B -1 REMARK 465 THR B 0 REMARK 465 ALA B 105 REMARK 465 ARG B 106 REMARK 465 VAL D 113 REMARK 465 ARG D 576 REMARK 465 GLU D 577 REMARK 465 ALA D 578 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 52 CD CE NZ REMARK 470 GLU A 67 CG CD OE1 OE2 REMARK 470 GLN C 140 CD OE1 NE2 REMARK 470 CYS C 150 SG REMARK 470 ARG C 185 CD NE CZ NH1 NH2 REMARK 470 GLN C 201 CD OE1 NE2 REMARK 470 ARG C 202 CG CD NE CZ NH1 NH2 REMARK 470 GLN C 204 CG CD OE1 NE2 REMARK 470 ASN C 215 CG OD1 ND2 REMARK 470 ARG C 226 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 307 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 314 CD NE CZ NH1 NH2 REMARK 470 ARG C 349 CG CD NE CZ NH1 NH2 REMARK 470 GLU C 354 CG CD OE1 OE2 REMARK 470 GLU C 446 CG CD OE1 OE2 REMARK 470 LYS C 463 CG CD CE NZ REMARK 470 GLU C 466 CG CD OE1 OE2 REMARK 470 ARG C 487 CD NE CZ NH1 NH2 REMARK 470 LYS C 488 CD CE NZ REMARK 470 GLU C 517 CG CD OE1 OE2 REMARK 470 MET C 522 CG SD CE REMARK 470 LYS C 548 CD CE NZ REMARK 470 ARG C 559 CD NE CZ NH1 NH2 REMARK 470 ASN C 563 CG OD1 ND2 REMARK 470 LYS B 52 CD CE NZ REMARK 470 GLU B 67 CG CD OE1 OE2 REMARK 470 GLN D 140 CD OE1 NE2 REMARK 470 CYS D 150 SG REMARK 470 ARG D 185 CD NE CZ NH1 NH2 REMARK 470 GLN D 201 CD OE1 NE2 REMARK 470 ARG D 202 CG CD NE CZ NH1 NH2 REMARK 470 GLN D 204 CG CD OE1 NE2 REMARK 470 ASN D 215 CG OD1 ND2 REMARK 470 ARG D 226 CG CD NE CZ NH1 NH2 REMARK 470 ARG D 307 CG CD NE CZ NH1 NH2 REMARK 470 ARG D 314 CD NE CZ NH1 NH2 REMARK 470 ARG D 349 CG CD NE CZ NH1 NH2 REMARK 470 GLU D 354 CG CD OE1 OE2 REMARK 470 GLU D 446 CG CD OE1 OE2 REMARK 470 LYS D 463 CG CD CE NZ REMARK 470 GLU D 466 CG CD OE1 OE2 REMARK 470 ARG D 487 CD NE CZ NH1 NH2 REMARK 470 LYS D 488 CD CE NZ REMARK 470 GLU D 517 CG CD OE1 OE2 REMARK 470 MET D 522 CG SD CE REMARK 470 LYS D 548 CD CE NZ REMARK 470 ARG D 559 CD NE CZ NH1 NH2 REMARK 470 ASN D 563 CG OD1 ND2 REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE EXACT CHEMICAL STRUCTURE OF THE HEME IN REMARK 600 MYELOPEROXIDASE IS NOT KNOWN. THE AUTHORS HAVE USED REMARK 600 PROTOPORPHYRIN IX AS A MODEL. A HEME IS COVALENTLY BOUND REMARK 600 TO THE LARGE POLYPEPTIDE IN EACH HALF OF THE MOLECULE, BUT REMARK 600 THE CHEMICAL NATURE OF THE LINK IS NOT KNOWN. THE LINK REMARK 600 APPEARS TO INVOLVE THE CARBOXYLATE GROUP OF GLU 242. REMARK 600 REMARK 600 EACH HALF-MOLECULE INCLUDES A BOUND CALCIUM ION WITH REMARK 600 POSSIBLE LIGANDS INCLUDING: ASP 96 CARBOXYLATE OXYGEN, REMARK 600 ASP 96 PEPTIDE CARBONYL OXYGEN, THR 168 HYDROXYL OXYGEN, REMARK 600 PHE 170 PEPTIDE CARBONYL OXYGEN, ASP 172 CARBOXYLATE REMARK 600 OXYGEN, AND SER 174 HYDROXYL OXYGEN. REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 581 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 96 O REMARK 620 2 ASP A 96 OD1 77.3 REMARK 620 3 THR C 168 OG1 108.5 137.0 REMARK 620 4 THR C 168 O 62.6 139.9 63.9 REMARK 620 5 PHE C 170 O 109.9 107.1 110.2 86.3 REMARK 620 6 ASP C 172 OD1 164.5 99.7 63.2 119.3 85.5 REMARK 620 7 SER C 174 OG 100.9 68.7 68.4 118.4 147.3 64.2 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 580 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS C 336 NE2 REMARK 620 2 HEM A 580 NA 113.8 REMARK 620 3 HEM A 580 NB 71.5 90.8 REMARK 620 4 HEM A 580 NC 80.3 164.9 88.5 REMARK 620 5 HEM A 580 ND 112.6 95.5 170.0 83.4 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B 581 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 96 OD1 REMARK 620 2 ASP B 96 O 75.2 REMARK 620 3 THR D 168 OG1 161.7 119.2 REMARK 620 4 THR D 168 O 123.6 71.1 58.1 REMARK 620 5 PHE D 170 O 73.8 111.4 89.7 78.3 REMARK 620 6 ASP D 172 OD1 84.0 159.2 81.5 123.5 62.6 REMARK 620 7 SER D 174 OG 94.2 114.7 89.6 140.8 127.1 65.0 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 580 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS D 336 NE2 REMARK 620 2 HEM B 580 NA 80.9 REMARK 620 3 HEM B 580 NB 66.6 85.7 REMARK 620 4 HEM B 580 NC 95.5 176.4 93.5 REMARK 620 5 HEM B 580 ND 102.4 94.7 168.8 85.4 REMARK 620 N 1 2 3 4 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE SEQUENCE FOR HUMAN MYELOPEROXIDASE HAS BEEN USED TO REMARK 999 INTERPRET THE ELECTRON DENSITY MAP OF DOG MYELOPEROXIDASE. REMARK 999 THE SEQUENCE NUMBERING BEGINNING WITH CYS 1 WAS CHOSEN TO REMARK 999 FACILITATE COMPARISONS BETWEEN OTHER MEMBERS OF THE GENE REMARK 999 FAMILY INCLUDING LACTOPEROXIDASE, EOSINOPHIL PEROXIDASE REMARK 999 AND THYROID PEROXIDASE. AMINO-TERMINAL SEQUENCING HAS REMARK 999 INDICATED 2 RESIDUES PRIOR TO THIS CYSTEINE (VAL, THR) IN REMARK 999 HUMAN MYELOPEROXIDASE. DBREF 1MYP A -1 106 UNP P05164 PERM_HUMAN 165 272 DBREF 1MYP C 113 578 UNP P05164 PERM_HUMAN 279 744 DBREF 1MYP B -1 106 UNP P05164 PERM_HUMAN 165 272 DBREF 1MYP D 113 578 UNP P05164 PERM_HUMAN 279 744 SEQRES 1 A 108 VAL THR CYS PRO GLU GLN ASP LYS TYR ARG THR ILE THR SEQRES 2 A 108 GLY MET CYS ASN ASN ARG ARG SER PRO THR LEU GLY ALA SEQRES 3 A 108 SER ASN ARG ALA PHE VAL ARG TRP LEU PRO ALA GLU TYR SEQRES 4 A 108 GLU ASP GLY PHE SER LEU PRO TYR GLY TRP THR PRO GLY SEQRES 5 A 108 VAL LYS ARG ASN GLY PHE PRO VAL ALA LEU ALA ARG ALA SEQRES 6 A 108 VAL SER ASN GLU ILE VAL ARG PHE PRO THR ASP GLN LEU SEQRES 7 A 108 THR PRO ASP GLN GLU ARG SER LEU MET PHE MET GLN TRP SEQRES 8 A 108 GLY GLN LEU LEU ASP HIS ASP LEU ASP PHE THR PRO GLU SEQRES 9 A 108 PRO ALA ALA ARG SEQRES 1 C 466 VAL ASN CYS GLU THR SER CYS VAL GLN GLN PRO PRO CYS SEQRES 2 C 466 PHE PRO LEU LYS ILE PRO PRO ASN ASP PRO ARG ILE LYS SEQRES 3 C 466 ASN GLN ALA ASP CYS ILE PRO PHE PHE ARG SER CYS PRO SEQRES 4 C 466 ALA CYS PRO GLY SER ASN ILE THR ILE ARG ASN GLN ILE SEQRES 5 C 466 ASN ALA LEU THR SER PHE VAL ASP ALA SER MET VAL TYR SEQRES 6 C 466 GLY SER GLU GLU PRO LEU ALA ARG ASN LEU ARG ASN MET SEQRES 7 C 466 SER ASN GLN LEU GLY LEU LEU ALA VAL ASN GLN ARG PHE SEQRES 8 C 466 GLN ASP ASN GLY ARG ALA LEU LEU PRO PHE ASP ASN LEU SEQRES 9 C 466 HIS ASP ASP PRO CYS LEU LEU THR ASN ARG SER ALA ARG SEQRES 10 C 466 ILE PRO CYS PHE LEU ALA GLY ASP THR ARG SER SER GLU SEQRES 11 C 466 MET PRO GLU LEU THR SER MET HIS THR LEU LEU LEU ARG SEQRES 12 C 466 GLU HIS ASN ARG LEU ALA THR GLU LEU LYS SER LEU ASN SEQRES 13 C 466 PRO ARG TRP ASP GLY GLU ARG LEU TYR GLN GLU ALA ARG SEQRES 14 C 466 LYS ILE VAL GLY ALA MET VAL GLN ILE ILE THR TYR ARG SEQRES 15 C 466 ASP TYR LEU PRO LEU VAL LEU GLY PRO THR ALA MET ARG SEQRES 16 C 466 LYS TYR LEU PRO THR TYR ARG SER TYR ASN ASP SER VAL SEQRES 17 C 466 ASP PRO ARG ILE ALA ASN VAL PHE THR ASN ALA PHE ARG SEQRES 18 C 466 TYR GLY HIS THR LEU ILE GLN PRO PHE MET PHE ARG LEU SEQRES 19 C 466 ASP ASN ARG TYR GLN PRO MET GLU PRO ASN PRO ARG VAL SEQRES 20 C 466 PRO LEU SER ARG VAL PHE PHE ALA SER TRP ARG VAL VAL SEQRES 21 C 466 LEU GLU GLY GLY ILE ASP PRO ILE LEU ARG GLY LEU MET SEQRES 22 C 466 ALA THR PRO ALA LYS LEU ASN ARG GLN ASN GLN ILE ALA SEQRES 23 C 466 VAL ASP GLU ILE ARG GLU ARG LEU PHE GLU GLN VAL MET SEQRES 24 C 466 ARG ILE GLY LEU ASP LEU PRO ALA LEU ASN MET GLN ARG SEQRES 25 C 466 SER ARG ASP HIS GLY LEU PRO GLY TYR ASN ALA TRP ARG SEQRES 26 C 466 ARG PHE CYS GLY LEU PRO GLN PRO GLU THR VAL GLY GLN SEQRES 27 C 466 LEU GLY THR VAL LEU ARG ASN LEU LYS LEU ALA ARG LYS SEQRES 28 C 466 LEU MET GLU GLN TYR GLY THR PRO ASN ASN ILE ASP ILE SEQRES 29 C 466 TRP MET GLY GLY VAL SER GLU PRO LEU LYS ARG LYS GLY SEQRES 30 C 466 ARG VAL GLY PRO LEU LEU ALA CYS ILE ILE GLY THR GLN SEQRES 31 C 466 PHE ARG LYS LEU ARG ASP GLY ASP ARG PHE TRP TRP GLU SEQRES 32 C 466 ASN GLU GLY VAL PHE SER MET GLN GLN ARG GLN ALA LEU SEQRES 33 C 466 ALA GLN ILE SER LEU PRO ARG ILE ILE CYS ASP ASN THR SEQRES 34 C 466 GLY ILE THR THR VAL SER LYS ASN ASN ILE PHE MET SER SEQRES 35 C 466 ASN SER TYR PRO ARG ASP PHE VAL ASN CYS SER THR LEU SEQRES 36 C 466 PRO ALA LEU ASN LEU ALA SER TRP ARG GLU ALA SEQRES 1 B 108 VAL THR CYS PRO GLU GLN ASP LYS TYR ARG THR ILE THR SEQRES 2 B 108 GLY MET CYS ASN ASN ARG ARG SER PRO THR LEU GLY ALA SEQRES 3 B 108 SER ASN ARG ALA PHE VAL ARG TRP LEU PRO ALA GLU TYR SEQRES 4 B 108 GLU ASP GLY PHE SER LEU PRO TYR GLY TRP THR PRO GLY SEQRES 5 B 108 VAL LYS ARG ASN GLY PHE PRO VAL ALA LEU ALA ARG ALA SEQRES 6 B 108 VAL SER ASN GLU ILE VAL ARG PHE PRO THR ASP GLN LEU SEQRES 7 B 108 THR PRO ASP GLN GLU ARG SER LEU MET PHE MET GLN TRP SEQRES 8 B 108 GLY GLN LEU LEU ASP HIS ASP LEU ASP PHE THR PRO GLU SEQRES 9 B 108 PRO ALA ALA ARG SEQRES 1 D 466 VAL ASN CYS GLU THR SER CYS VAL GLN GLN PRO PRO CYS SEQRES 2 D 466 PHE PRO LEU LYS ILE PRO PRO ASN ASP PRO ARG ILE LYS SEQRES 3 D 466 ASN GLN ALA ASP CYS ILE PRO PHE PHE ARG SER CYS PRO SEQRES 4 D 466 ALA CYS PRO GLY SER ASN ILE THR ILE ARG ASN GLN ILE SEQRES 5 D 466 ASN ALA LEU THR SER PHE VAL ASP ALA SER MET VAL TYR SEQRES 6 D 466 GLY SER GLU GLU PRO LEU ALA ARG ASN LEU ARG ASN MET SEQRES 7 D 466 SER ASN GLN LEU GLY LEU LEU ALA VAL ASN GLN ARG PHE SEQRES 8 D 466 GLN ASP ASN GLY ARG ALA LEU LEU PRO PHE ASP ASN LEU SEQRES 9 D 466 HIS ASP ASP PRO CYS LEU LEU THR ASN ARG SER ALA ARG SEQRES 10 D 466 ILE PRO CYS PHE LEU ALA GLY ASP THR ARG SER SER GLU SEQRES 11 D 466 MET PRO GLU LEU THR SER MET HIS THR LEU LEU LEU ARG SEQRES 12 D 466 GLU HIS ASN ARG LEU ALA THR GLU LEU LYS SER LEU ASN SEQRES 13 D 466 PRO ARG TRP ASP GLY GLU ARG LEU TYR GLN GLU ALA ARG SEQRES 14 D 466 LYS ILE VAL GLY ALA MET VAL GLN ILE ILE THR TYR ARG SEQRES 15 D 466 ASP TYR LEU PRO LEU VAL LEU GLY PRO THR ALA MET ARG SEQRES 16 D 466 LYS TYR LEU PRO THR TYR ARG SER TYR ASN ASP SER VAL SEQRES 17 D 466 ASP PRO ARG ILE ALA ASN VAL PHE THR ASN ALA PHE ARG SEQRES 18 D 466 TYR GLY HIS THR LEU ILE GLN PRO PHE MET PHE ARG LEU SEQRES 19 D 466 ASP ASN ARG TYR GLN PRO MET GLU PRO ASN PRO ARG VAL SEQRES 20 D 466 PRO LEU SER ARG VAL PHE PHE ALA SER TRP ARG VAL VAL SEQRES 21 D 466 LEU GLU GLY GLY ILE ASP PRO ILE LEU ARG GLY LEU MET SEQRES 22 D 466 ALA THR PRO ALA LYS LEU ASN ARG GLN ASN GLN ILE ALA SEQRES 23 D 466 VAL ASP GLU ILE ARG GLU ARG LEU PHE GLU GLN VAL MET SEQRES 24 D 466 ARG ILE GLY LEU ASP LEU PRO ALA LEU ASN MET GLN ARG SEQRES 25 D 466 SER ARG ASP HIS GLY LEU PRO GLY TYR ASN ALA TRP ARG SEQRES 26 D 466 ARG PHE CYS GLY LEU PRO GLN PRO GLU THR VAL GLY GLN SEQRES 27 D 466 LEU GLY THR VAL LEU ARG ASN LEU LYS LEU ALA ARG LYS SEQRES 28 D 466 LEU MET GLU GLN TYR GLY THR PRO ASN ASN ILE ASP ILE SEQRES 29 D 466 TRP MET GLY GLY VAL SER GLU PRO LEU LYS ARG LYS GLY SEQRES 30 D 466 ARG VAL GLY PRO LEU LEU ALA CYS ILE ILE GLY THR GLN SEQRES 31 D 466 PHE ARG LYS LEU ARG ASP GLY ASP ARG PHE TRP TRP GLU SEQRES 32 D 466 ASN GLU GLY VAL PHE SER MET GLN GLN ARG GLN ALA LEU SEQRES 33 D 466 ALA GLN ILE SER LEU PRO ARG ILE ILE CYS ASP ASN THR SEQRES 34 D 466 GLY ILE THR THR VAL SER LYS ASN ASN ILE PHE MET SER SEQRES 35 D 466 ASN SER TYR PRO ARG ASP PHE VAL ASN CYS SER THR LEU SEQRES 36 D 466 PRO ALA LEU ASN LEU ALA SER TRP ARG GLU ALA MODRES 1MYP ASN C 189 ASN GLYCOSYLATION SITE MODRES 1MYP ASN C 225 ASN GLYCOSYLATION SITE MODRES 1MYP ASN C 317 ASN GLYCOSYLATION SITE MODRES 1MYP ASN D 189 ASN GLYCOSYLATION SITE MODRES 1MYP ASN D 225 ASN GLYCOSYLATION SITE MODRES 1MYP ASN D 317 ASN GLYCOSYLATION SITE HET NAG E 1 14 HET NAG E 2 14 HET NAG F 1 14 HET NAG F 2 14 HET NAG G 1 14 HET NAG G 2 14 HET NAG H 1 14 HET NAG H 2 14 HET NAG I 1 14 HET NAG I 2 14 HET NAG J 1 14 HET NAG J 2 14 HET CA A 581 1 HET HEM A 580 43 HET CA B 581 1 HET HEM B 580 43 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM CA CALCIUM ION HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETSYN HEM HEME FORMUL 5 NAG 12(C8 H15 N O6) FORMUL 11 CA 2(CA 2+) FORMUL 12 HEM 2(C34 H32 FE N4 O4) HELIX 1 A1 ALA A 61 VAL A 69 1HELICES ALL RIGHT-HANDED 9 HELIX 2 A2 LEU A 84 LEU A 97 1 14 HELIX 3 C3 GLU C 181 LEU C 187 1 7 HELIX 4 C4 PRO C 220 THR C 224 1 5 HELIX 5 C5 PRO C 244 LEU C 267 1 24 HELIX 6 C6 GLY C 273 LEU C 301 1 29 HELIX 7 C7 PRO C 303 TYR C 309 1 7 HELIX 8 C8 ASN C 326 LEU C 338 1 13 HELIX 9 C9 SER C 368 GLU C 374 1 7 HELIX 10 C10 ILE C 377 MET C 385 1 9 HELIX 11 H11 ASP C 400 ARG C 405 1 6 HELIX 12 H12 LEU C 417 HIS C 428 1 12 HELIX 13 H13 TYR C 433 PHE C 439 1 7 HELIX 14 H14 VAL C 448 LEU C 455 1 8 HELIX 15 H15 LEU C 458 GLN C 467 1 10 HELIX 16 H16 ILE C 476 SER C 482 1 7 HELIX 17 H17 PRO C 493 GLY C 509 1 17 HELIX 18 H18 MET C 522 ALA C 529 1 8 HELIX 19 H19 LEU C 533 ASN C 540 1 8 HELIX 20 B1 ALA B 61 VAL B 69 1 9 HELIX 21 B2 LEU B 84 LEU B 97 1 14 HELIX 22 D3 GLU D 181 LEU D 187 1 7 HELIX 23 D4 PRO D 220 THR D 224 1 5 HELIX 24 D5 PRO D 244 LEU D 267 1 24 HELIX 25 D6 GLY D 273 LEU D 301 1 29 HELIX 26 D7 PRO D 303 TYR D 309 1 7 HELIX 27 D8 ASN D 326 LEU D 338 1 13 HELIX 28 D9 SER D 368 GLU D 374 1 7 HELIX 29 D10 ILE D 377 MET D 385 1 9 HELIX 30 D11 ASP D 400 ARG D 405 1 6 HELIX 31 D12 LEU D 417 HIS D 428 1 12 HELIX 32 D13 TYR D 433 PHE D 439 1 7 HELIX 33 D14 VAL D 448 LEU D 455 1 8 HELIX 34 D15 LEU D 458 GLN D 467 1 10 HELIX 35 D16 ILE D 476 SER D 482 1 7 HELIX 36 D17 PRO D 493 GLY D 509 1 17 HELIX 37 D18 MET D 522 ALA D 529 1 8 HELIX 38 D19 LEU D 533 ASN D 540 1 8 SHEET 1 A 2 ARG A 27 ALA A 28 0 SHEET 1 B 2 PRO A 78 SER A 83 0 SHEET 1 F 2 ILE D 164 ASN D 165 0 SHEET 1 G 2 PRO D 388 LYS D 390 0 SHEET 1 H 2 LEU D 128 LYS D 129 0 SHEET 2 H 2 CYS D 143 ILE D 144 -1 O ILE D 144 N LEU D 128 SHEET 1 I 2 ARG D 188 ASN D 189 0 SHEET 2 I 2 LEU D 196 LEU D 197 -1 O LEU D 196 N ASN D 189 SHEET 1 J 2 PHE D 342 PHE D 344 0 SHEET 2 J 2 ARG D 358 PRO D 360 -1 N VAL D 359 O MET D 343 SSBOND 1 CYS A 1 CYS A 14 1555 1555 2.04 SSBOND 2 CYS C 115 CYS C 125 1555 1555 2.04 SSBOND 3 CYS C 119 CYS C 143 1555 1555 2.06 SSBOND 4 CYS C 153 CYS D 153 1555 1555 2.01 SSBOND 5 CYS C 221 CYS C 232 1555 1555 2.03 SSBOND 6 CYS C 440 CYS C 497 1555 1555 2.02 SSBOND 7 CYS C 538 CYS C 564 1555 1555 2.05 SSBOND 8 CYS B 1 CYS B 14 1555 1555 2.04 SSBOND 9 CYS D 115 CYS D 125 1555 1555 2.03 SSBOND 10 CYS D 119 CYS D 143 1555 1555 2.05 SSBOND 11 CYS D 221 CYS D 232 1555 1555 2.04 SSBOND 12 CYS D 440 CYS D 497 1555 1555 2.05 SSBOND 13 CYS D 538 CYS D 564 1555 1555 2.04 LINK ND2 ASN C 189 C1 NAG F 1 1555 1555 1.47 LINK ND2 ASN C 225 C1 NAG G 1 1555 1555 1.42 LINK OD1 ASN C 225 O5 NAG G 1 1555 1555 1.83 LINK ND2 ASN C 317 C1 NAG E 1 1555 1555 1.48 LINK ND2 ASN D 189 C1 NAG I 1 1555 1555 1.46 LINK ND2 ASN D 225 C1 NAG J 1 1555 1555 1.44 LINK ND2 ASN D 317 C1 NAG H 1 1555 1555 1.44 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.43 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.41 LINK O4 NAG G 1 C1 NAG G 2 1555 1555 1.39 LINK O4 NAG H 1 C1 NAG H 2 1555 1555 1.40 LINK O4 NAG I 1 C1 NAG I 2 1555 1555 1.40 LINK O4 NAG J 1 C1 NAG J 2 1555 1555 1.37 LINK O ASP A 96 CA CA A 581 1555 1555 2.17 LINK OD1 ASP A 96 CA CA A 581 1555 1555 1.64 LINK FE HEM A 580 NE2 HIS C 336 1555 1555 2.21 LINK CA CA A 581 OG1 THR C 168 1555 1555 2.50 LINK CA CA A 581 O THR C 168 1555 1555 2.61 LINK CA CA A 581 O PHE C 170 1555 1555 2.37 LINK CA CA A 581 OD1 ASP C 172 1555 1555 2.16 LINK CA CA A 581 OG SER C 174 1555 1555 2.34 LINK OD1 ASP B 96 CA CA B 581 1555 1555 2.32 LINK O ASP B 96 CA CA B 581 1555 1555 2.16 LINK FE HEM B 580 NE2 HIS D 336 1555 1555 2.46 LINK CA CA B 581 OG1 THR D 168 1555 1555 1.94 LINK CA CA B 581 O THR D 168 1555 1555 2.55 LINK CA CA B 581 O PHE D 170 1555 1555 2.74 LINK CA CA B 581 OD1 ASP D 172 1555 1555 1.89 LINK CA CA B 581 OG SER D 174 1555 1555 2.31 CRYST1 133.000 133.000 203.600 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007519 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007519 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004912 0.00000